Topic List : Stem Cells
Cell, gene medicine lab opens
Making cell- or virus-based therapies for use in humans requires a rigid set of quality-control standards outlined by the Food and Drug Administration. A new Stanford facility will allow promising new therapies to be tested in the clinic.
A safer way for bone marrow transplants
Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects.
Antibodies could counter atherosclerosis
A biological drug could be used to combat cardiovascular disease by targeting not mere risk factors such as high cholesterol or high blood pressure, but the actual lesions bearing direct responsibility: atherosclerotic plaques.
Coaxing stem cells to quickly specialize
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
Stem-cell therapy for stroke trial successful
People disabled by a stroke demonstrated substantial recovery long after the event when modified adult stem cells were injected into their brains.
Keeping muscle stem cells happy in the lab
Artificial collagen-based muscle fibers and a specialized broth developed by Stanford researchers help muscle stem cells stay primed and ready for transplant.
Stem cell grants given to researchers
Albert Wong receives $2.9 million to develop vaccine for glioblastoma; four others awarded $240,000 each to study bladder, heart and eye conditions.
IPS cells aid study of chemotherapy side effect
Doxorubicin is a chemotherapy drug used to treat many cancers, but it causes serious heart damage in some patients. Heart muscle cells made from the skin cells of breast cancer patients can be used to study this phenomenon.
Key blood stem cell marker identified
Nearly 30 years after the discovery of the hematopoietic stem cell, Stanford researchers have found a marker that allows them to study the version of these stem cells that continues to replicate.
From Montana to California, and back again
Irving Weissman had an unconventional start in science. The son of a hardware store operator and grandson of a fur trader, he learned lifelong lessons in research at the McLaughlin Research Institute in Montana.